Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells

Sci Rep. 2018 Aug 21;8(1):12507. doi: 10.1038/s41598-018-30062-z.

Abstract

The concept that human cancer is in essence a genetic disease driven by gene mutations has been well established, yet its utilization in functional studies of cancer genes has not been fully explored. Here, we describe a simple genetics-based approach that can quickly and sensitively reveal the effect of the alteration of a gene of interest on the fate of its host cells within a heterogeneous population, essentially monitoring the genetic selection that is associated with and powers the tumorigenesis. Using this approach, we discovered that loss-of-function of TP53 can promote the development of resistance of castration in prostate cancer cells via both transiently potentiating androgen-independent cell growth and facilitating the occurrence of genome instability. The study thus reveals a novel genetic basis underlying the development of castration resistance in prostate cancer cells and provides a facile genetic approach for studying a cancer gene of interest in versatile experimental conditions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation
  • Genomic Instability
  • HCT116 Cells
  • HEK293 Cells
  • Humans
  • Loss of Function Mutation*
  • Male
  • Mice
  • Prostatic Neoplasms, Castration-Resistant / genetics*
  • Tumor Suppressor Protein p53 / genetics*
  • Xenograft Model Antitumor Assays

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53